tiprankstipranks
Advertisement
Advertisement

DE:BM8 Stock Latest News

Trump Trade: U.S. considering new semiconductor tariffs
The FlyTrump Trade: U.S. considering new semiconductor tariffs
3d ago
MU
AMD
White House to announce drug pricing deals with biotechs, Bloomberg reports
PremiumThe Fly
White House to announce drug pricing deals with biotechs, Bloomberg reports
4d ago
ALKS
ALNY
BioMarin Acquisition of Alesta Therapeutics Reinforces Growth Strategy; Whitney Ijem Reiterates Buy Rating and Maintains $114 Price Target
PremiumRatings
BioMarin Acquisition of Alesta Therapeutics Reinforces Growth Strategy; Whitney Ijem Reiterates Buy Rating and Maintains $114 Price Target
11d ago
BMRN
BMO starts BioMarin at Outperform, sees slower fade for Voxzogo
PremiumThe Fly
BMO starts BioMarin at Outperform, sees slower fade for Voxzogo
12d ago
BMRN
BioMarin initiated with an Outperform at BMO Capital
PremiumThe Fly
BioMarin initiated with an Outperform at BMO Capital
12d ago
BMRN
BioMarin price target lowered to $59 from $60 at H.C. Wainwright
PremiumThe FlyBioMarin price target lowered to $59 from $60 at H.C. Wainwright
12d ago
BMRN
BioMarin to Acquire Alesta Therapeutics, Expanding Skeletal Pipeline
Premium
Company Announcements
BioMarin to Acquire Alesta Therapeutics, Expanding Skeletal Pipeline
12d ago
8K
BMRN
BioMarin to acquire Alesta Therapeutics for $275M plus payments
Premium
The Fly
BioMarin to acquire Alesta Therapeutics for $275M plus payments
12d ago
BMRN
BioMarin price target raised to $88 from $82 at Piper Sandler
PremiumThe Fly
BioMarin price target raised to $88 from $82 at Piper Sandler
13d ago
BMRN
BioMarin price target raised to $111 from $105 at Barclays
PremiumThe Fly
BioMarin price target raised to $111 from $105 at Barclays
13d ago
BMRN
BioMarin price target raised to $114 from $111 at Canaccord
PremiumThe Fly
BioMarin price target raised to $114 from $111 at Canaccord
20d ago
BMRN
BioMarin price target raised to $80 from $75 at Wells Fargo
PremiumThe Fly
BioMarin price target raised to $80 from $75 at Wells Fargo
20d ago
BMRN
BioMarin price target raised to $86 from $80 at BofA
PremiumThe FlyBioMarin price target raised to $86 from $80 at BofA
23d ago
BMRN
BioMarin price target raised to $124 from $119 at Morgan Stanley
Premium
The Fly
BioMarin price target raised to $124 from $119 at Morgan Stanley
23d ago
BMRN
BioMarin price target raised to $105 from $100 at Raymond James
Premium
The Fly
BioMarin price target raised to $105 from $100 at Raymond James
23d ago
BMRN
BioMarin Buy Rating Reaffirmed as Strong Voxzogo Performance and Pipeline Progress Support Durable Growth; $94 Price Target Maintained
PremiumRatings
BioMarin Buy Rating Reaffirmed as Strong Voxzogo Performance and Pipeline Progress Support Durable Growth; $94 Price Target Maintained
23d ago
BMRN
BioMarin price target raised to $70 from $68 at Stifel
PremiumThe Fly
BioMarin price target raised to $70 from $68 at Stifel
23d ago
BMRN
BioMarin price target raised to $97 from $95 at Oppenheimer
PremiumThe Fly
BioMarin price target raised to $97 from $95 at Oppenheimer
23d ago
BMRN
BioMarin price target raised to $60 from $50 at H.C. Wainwright
PremiumThe Fly
BioMarin price target raised to $60 from $50 at H.C. Wainwright
23d ago
BMRN
BioMarin reports Q2 non-GAAP EPS $1.20, consensus 95c
PremiumThe FlyBioMarin reports Q2 non-GAAP EPS $1.20, consensus 95c
24d ago
BMRN
BioMarin raises 2026 non-GAAP EPS view to $4.90-$5.10 from $4.85-$5.05
Premium
The Fly
BioMarin raises 2026 non-GAAP EPS view to $4.90-$5.10 from $4.85-$5.05
24d ago
BMRN
Is BMRN a Buy, Before Earnings?
Premium
Pre-Earnings
Is BMRN a Buy, Before Earnings?
26d ago
BMRN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >